Legal Opinion
Chatman v. Pfizer, Inc.
District Court, S.D. Mississippi
Decided March 28, 2013No. Case No. 5:11-CV-69-DCB-JMRPublishedCited by 7 opinions
1Opinion of the Court
MEMORANDUM OPINION AND ORDER
DAVID BRAMLETTE, District Judge.
Plaintiff Annie Chatman brings suit in this Court pursuant to 28 U.S.C. § 1332 against Defendants Pfizer, Inc., Wyeth LLC, and Schwarz Pharma, Inc. N/K/A UCB, Inc., manufacturers of the brand-name drug Reglan (collectively, Brand Defendants), and Defendants Pliva, Inc., Barr Laboratories, Inc., and Teva Pharmaceuticals USA, Inc., manufacturers of Reglan’s generic equivalent, metoclopramide (collectively, Generic Defendants). The First Amended Complaint [docket no. 55] alleges that, after taking metoclopramide, Chatman developed…
2Cases cited35 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
- Matsushita Electric Industrial Co., Ltd. v. Zenith Radio CorporationSupreme Court of the United States · 1986
30 more not listed; retrieve them via the Exa API.
3Cited by7 opinions
- T.H. v. Novartis Pharmaceuticals CorporationCalifornia Supreme Court · 2017
- Dolin v. SmithKline Beecham Corp.District Court, N.D. Illinois · 2014
- McNair v. Johnson & JohnsonWest Virginia Supreme Court · 2018
- Akerman v. GlaxoSmithKline, LCCDistrict Court, D. Massachusetts · 2017
- Munson v. C.R. Bard, Inc.District Court, N.D. Mississippi · 2021
2 more not listed; retrieve them via the Exa API.